SCHEMBL8744160

SCHEMBL8744160

CCC=CC(=O)[C@H]1C(C(C)(C)C)[C@@](n2cc(C)c(=O)[nH]c2=O)([SiH](C)C)O[C@@H]1CO

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TK1 P04183 5/20 0.36
TK2 O00142 3/20 0.34
TYMP P19971 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8744204 0.83 TK1 (0.40) TK1TK2TYMP
SCHEMBL8744146 0.82 TK1 (0.39) TK1TYMP
SCHEMBL8987848 0.76 TK1 (0.36) TK1TK2TYMP
SCHEMBL8859641 0.73 TK1 (0.34) TK1
SCHEMBL8538169 0.71 TK2 (0.42) TK1TK2TYMP
SCHEMBL9396549 0.70 RNASE1 (0.39) TK1TK2
SCHEMBL9216459 0.70 ALDH1A1 (0.35) TK1TK2
SCHEMBL8744135 0.70 TK1 (0.38) TK1TK2
SCHEMBL28294848 0.69 ALDH1A1 (0.34) TK1TK2
SCHEMBL28293120 0.66 LMNA (0.36) TK1TK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0753002-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1997-01-15 EP disclosed
WO-1995026972-A1 MODIFIED OLIGONUCLEOTIDES AND INTERMEDIATES USEFUL IN NUCLEIC ACID THERAPEUTICS AMGEN INC. (US) 1995-10-12 WO disclosed